Bay Area boy celebrates year in remission from rare blood cancer

A 3-year-old boy from the Bay Area is marking a year in remission after being diagnosed with a rare blood cancer as an infant, CBS News Bay Area reported. The child was initially diagnosed with Langerhans cell histiocytosis (LCH), a condition that causes tumors or lesions in various parts of the body, including his gums, behind his eye, and near the base of his brain.

After chemotherapy and steroid treatments stopped working, the boy enrolled in a 12-month clinical trial at UC San Francisco where he received a medication called tovorafenib once a week, CBS News Bay Area said. This drug targets the specific mutation that drives most LCH cases, aiming to kill only the LCH cells.

Dr. Russell Valle, a pediatric oncologist at UCSF, explained that clinical trials like this are initially for patients whose disease has returned or not responded to prior treatments. However, researchers are now gathering data to use these drugs earlier in treatment to help prevent relapses.

The boy's mother described him as a source of hope during his treatment, bringing encouragement to both family members and other children undergoing chemotherapy, CBS News Bay Area reported.